Glaucoma, Vision & Longevity: Supplements & Science
Discover the latest science on glaucoma, vision, and longevity. Each episode explores evidence-based supplements for eye health, healthy aging, and lifespan extension. Original articles backed by real scientific research. All source links available at visualfieldtest.com, where you can also take a free visual field test online. Subscribe for weekly insights on glaucoma treatment, glaucoma prevention, vision supplements, and longevity research that could protect your sight and extend your healthspan.
MEDICAL DISCLAIMER:
This podcast is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. The content presented should not replace professional medical consultation.
Glaucoma is a serious condition that can lead to permanent vision loss. Never stop or modify prescribed treatments without consulting your ophthalmologist or healthcare provider.
The supplements and research discussed are for informational purposes only. Individual results may vary, and supplements are not FDA-approved to treat, cure, or prevent any disease.
Always consult a qualified healthcare professional before starting any new supplement regimen, especially if you have existing eye conditions or are taking medications.
The visual field test available at visualfieldtest.com is a screening tool only and does not replace comprehensive eye exams by a licensed professional.
Episodes
Blue Zones and Centenarians: Ocular Phenotypes of Exceptional Agers
Metformin, Rapamycin, and Geroscience Drugs: Ocular Outcomes
ER-100 Clinical Trial for Glaucoma: What We Know So Far and What to Expect
Glaucoma Eye Drops, Dry Eye, and Sleep Quality: Exploring Hidden Connections and What Patients Can Do
The Ocular Microbiome, Inflammaging, and Surface Health
Methods of Visual Field Testing in Glaucoma: How They Differ and What Each Reveals
The Limitations of Visual Field Testing in Glaucoma: Frequency, Subjectivity, and What Gets Missed
Home Tonometry and Remote Monitoring in Glaucoma – A Patient-Centered Investigation
Predicting Glaucoma Before It Starts: How Close Are We to Genetic Risk Scores That Actually Change Patient Outcomes?
Glaucoma Clinical Trials Launched in 2025: A Complete Overview
Patterns of Vision Loss in Glaucoma: Large Blind Spots Versus Scattered Missing Points
How Fast Is AI Actually Progressing, and What Does It Mean for Glaucoma Patients and Researchers?
AI in Glaucoma: What's Working Now, What's Coming Next, and Where the Real Opportunities Lie
Glaucoma Vision Restoration: What's New in January 2026
Hydrogen Water Research Compiled: Studies, Dosages, Applications, and Outcomes
Pyruvate Supplementation for Glaucoma: Comparing Forms, Efficacy, and Global Availability
Nitric Oxide Pathway Supplements (L-Arginine, L-Citrulline) and Aqueous Outflow
Pyrroloquinoline Quinone (PQQ) and Mitochondrial Biogenesis in RGCs
Myopia and Glaucoma: When Nearsightedness Raises the Stakes
HDL cholesterol and apolipoprotein A-I: protective or paradoxical in glaucoma?
Complement proteins C3 and C4: systemic innate immunity and glaucoma progression
Systemic immune-inflammation index (SII) and the speed of RNFL loss
Coagulation markers (fibrinogen and D-dimer) and optic nerve microthrombosis
